My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

Gilead Sciences (NQ:GILD)

154.98 UNCHANGED

Streaming Delayed Price Updated: 4:00 PM EST, Feb 13, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Gilead Sciences

< Previous 1 2 3 4 5 6 7 8 9

...

51 52 Next >

How To Earn $500 A Month From Gilead Sciences Stock Ahead Of Q2 Earnings ↗

August 07, 2025

Via Benzinga

Apple Jumps, Eli Lilly Crashes On Worst Day In 25 Years: What's Moving Markets Thursday? ↗

August 07, 2025

U.S. equities slipped midday Thursday as corporate earnings and fresh tariff announcements from President Donald Trump drove divergent moves in heavyweight names.

Via Benzinga

Topics Government World Trade

Earnings Scheduled For August 7, 2025 ↗

August 07, 2025

Via Benzinga

Gilead Sciences's Earnings Outlook ↗

August 06, 2025

Via Benzinga

Price Over Earnings Overview: Gilead Sciences ↗

July 25, 2025

Via Benzinga

Upcoming Earnings Calls This Week: August 4th - August 10th, 2025

August 07, 2025

This week, from August 4th to August 10th, 2025, marks a busy period in the second-quarter earnings season, with hundreds of companies across various sectors scheduled to report their financial...

Via MarketMinute

Topics Artificial Intelligence Economy

Arcus (RCUS) Q2 Revenue Jumps 310% ↗

August 06, 2025

Via The Motley Fool

Gilead Sciences Inc (NASDAQ:GILD) Meets Caviar Cruise Quality Investing Criteria ↗

August 06, 2025

The Caviar Cruise strategy identifies high-quality stocks like Gilead Sciences (GILD) for long-term investment, focusing on strong growth, ROIC, low debt, and solid cash flow. GILD excels in...

Via Chartmill

Topics Economy

Gilead Sciences (GILD) Reports Q2: Everything You Need To Know Ahead Of Earnings

August 05, 2025

Biopharmaceutical company Gilead Sciences (NASDAQ:GILD) will be reporting results this Thursday after market close. Here’s what investors should know.

Via StockStory

Topics Artificial Intelligence World Trade

Tango (TNGX) Q2 Revenue Drops 52% ↗

August 05, 2025

Via The Motley Fool

Topics Intellectual Property

GILEAD SCIENCES INC (NASDAQ:GILD) Shows Strong Technical Breakout Potential with High Ratings ↗

August 04, 2025

Gilead Sciences (GILD) shows strong technical breakout potential with a high Technical Rating (10) and Setup Rating (8), indicating upward momentum and consolidation before a possible breakout.

Via Chartmill

Gilead Sciences Reports Earnings Thursday. Can The Highly Ranked Drugmaker Beat Its 237% Profit Surge Last Quarter? ↗

August 04, 2025

The upgraded score means Gilead is now outperforming 96% of all stocks in terms of the most important stock-picking criteria.

Via Investor's Business Daily

Pheton Holdings Dismisses Rumors Of Acquisition By Gilead, But Retail’s Extremely Optimistic ↗

August 01, 2025

pheton-holdings-dismisses-rumors-of-acquisition-by-gilead

Via Stocktwits

Topics Government

Trump Turns Up Heat On Big Pharma CEOs To Slash Drug Prices Within 60 Days — But Retail Traders Don't Flinch ↗

July 31, 2025

Via Stocktwits

Topics Government

Chinese Health Care Stock Pheton Holdings Collapses After Short Seller Warns Of Manipulation By 'Overseas Scammers' ↗

July 30, 2025

Via Benzinga

Why Gilead Sciences Stock Slipped Today ↗

July 28, 2025

Changes in a federal healthcare authority could negatively impact one of the company's important businesses.

Via The Motley Fool

BMO Capital Has An Important Take On Gilead Sciences, Retail’s Keeping The Optimism Alive ↗

July 28, 2025

The Supreme Court's Braidwood decision only concretized the power of the Department of Health and Human Services to decide what is necessary preventative care, rather than outright protecting...

Via Stocktwits

Visa, Disney, Blackstone And A Health Care Stock On CNBC's 'Final Trades' ↗

July 28, 2025

Visa, which will report third quarter results on Tuesday, July 29, is analyst Stephanie Link's final trade.

Via Benzinga

Why Gilead Sciences (GILD) Stock Is Up Today

July 25, 2025

Shares of biopharmaceutical company Gilead Sciences (NASDAQ:GILD) jumped 3% in the afternoon session after its long-acting HIV prevention injection, lenacapavir, received a recommendation for approval...

Via StockStory

Topics Stocks World Trade

Why Gilead Sciences Stock Just Popped ↗

July 25, 2025

Gilead stock is flashing "buy" in bright green letters.

Via The Motley Fool

Gilead's Newly Approved HIV Prevention Drug Poised To Add Billions To Future Sales ↗

July 25, 2025

Gilead upgraded to Buy by Needham as Yeztugo gains physician favor, with sales forecast to reach $6.4 billion by 2035, exceeding prior estimates.

Via Benzinga

This Gilead Sciences Analyst Turns Bullish; Here Are Top 5 Upgrades For Friday ↗

July 25, 2025

Via Benzinga

Gilead Gets Analyst Thumbs Up On Market Potential Of HIV-Prevention Injection, But Retail’s Not Ready To Cheer Yet ↗

July 25, 2025

Needham has a $133 price target on the stock, representing an upside of about 17.5% to the stock’s closing price on Thursday.

Via Stocktwits

Topics Workforce

1 Value Stock Worth Your Attention and 2 Facing Headwinds

July 24, 2025

Value investing has created more billionaires than any other strategy, like Warren Buffett, who built his fortune by purchasing wonderful businesses at reasonable prices. But these hidden gems are few...

Via StockStory

Topics Supply Chain

Director Sells 11,136 Shares of SRRK, a Stock Up 330% in Past Year ↗

July 23, 2025

Via The Motley Fool

Topics Regulatory Compliance

Gilead Sciences, Omnicom Group, and QuinStreet Shares Skyrocket, What You Need To Know

July 23, 2025

A number of stocks jumped in the afternoon session after a new trade agreement between the United States and Japan spurred a broad market rally.

Via StockStory

Topics Stocks World Trade

2 Large-Cap Stocks to Consider Right Now and 1 That Underwhelm

July 21, 2025

Large-cap stocks are known for their staying power and ability to weather market storms better than smaller competitors. However, their sheer size makes it more challenging to maintain high growth...

Via StockStory

Topics Supply Chain

Q1 Earnings Roundup: Gilead Sciences (NASDAQ:GILD) And The Rest Of The Therapeutics Segment

July 15, 2025

As the Q1 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the therapeutics industry, including Gilead Sciences (NASDAQ:GILD) and its peers.

Via StockStory

Topics Artificial Intelligence

Which S&P500 stocks are gapping on Tuesday? ↗

July 15, 2025

Wondering which stocks are making significant price gaps? Explore the S&P500 index on Tuesday to find the gap up and gap down stocks in today's session.

Via Chartmill

$100 Invested In This Stock 15 Years Ago Would Be Worth This Much Today ↗

July 14, 2025

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9

...

51 52 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.